Advanced Search

Revoke Authorisation Upon Renunciation, Commerciodel Medicinal Product For Human Use «Nopar»

Original Language Title: Revoca, su rinuncia, dell'autorizzazione all'immissione in commerciodel medicinale per uso umano «Nopar»

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
With no aRM-51/2015-1277 of February 26, 2015 's revoked, pursuant to art. 38, paragraph 9, of the Legislative Decree of April 24, 2006, no. 219, on renunciation of the firm Eli Lilly Italy S.p.a. the marketing authorisation for the medicinal product in the boxes indicated below.
Medicine: NOPAR.
Packaging: A.I.C. # 028507010-' 0.05 mg tablets» 30;
A.I.C. # 028507022-«0.25 mg tablets» 40;
A.I.C. # 028507034-«1 mg tablets» 20 tablets.